Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Revolution Medicines logo — Translating Frontier Oncology Targets to Outsmart Cancer

Revolution Medicines

Translating Frontier Oncology Targets to Outsmart Cancer

Founded 2014 United States Redwood City, United States 1339 employees IPO Total: $2.77B Biotechnology, Health Care +1

General Information

Company Name Revolution Medicines
Founded Year 2014
Location United States Redwood City, United States +1
Founders / Decision Makers
Team member Team member Team member
Employees 1339
Industries Biotechnology, Health Care, Life Sciences
Funding Stage IPO
Social

Get notified when Revolution Medicines moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Aug 13, 2026

Hiring for 76 positions in the last 30 days.

Get alerts when Revolution Medicines shows new signals

About Revolution Medicines

Revolution Medicines is a United States based startup focused on translating frontier oncology targets to outsmart cancer. Founded in 2015, the company is dedicated to discovering, developing, and delivering innovative, targeted medicines for patients living with cancer by relentlessly pursuing cutting-edge therapeutic approaches. At the forefront of their efforts is addressing RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses. The company recently secured a significant $323.60M Post-IPO Equity investment on 02 March 2023, demonstrating investor confidence in their mission. While details about the specific investors are not provided, this substantial investment speaks to the potential perceived by the investor community in Revolution Medicines' approach to tackling challenging cancers. As a player in the Health Care and Life Sciences industries, Revolution Medicines is positioning itself as a promising contender in the fight against cancer, poised to make a meaningful impact in the field of oncology.

Taxonomy: cancer therapy, oncology targets, drug discovery, small molecules, natural products, therapeutic approaches, biological function, pharmaceutical optimization, chemical synthesis, university collaboration

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post Ipo Equity •••••• - 01 Apr 2026
Post Ipo Debt •••••• - 01 Jun 2025
Post Ipo Equity •••••• - 01 Dec 2024
Post Ipo Equity •••••• 1
Investor
01 Feb 2024
Post Ipo Equity •••••• - 01 Mar 2023

View All 13 Funding Rounds

Latest News

View All
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage t... — Cnbc
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Cnbc Apr 13, 2026

Revolution Medicines Alternatives & Competitors

Revolution Medicines vs
Alliance for Cancer Gene Therapy
Alliance for Cancer Gene Therapy United States

Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...

10 employees
Health Care, Health and Wellness
Compare Revolution Medicines vs Alliance for Cancer Gene Therapy
Revolution Medicines vs
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals United States

Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver...

8 employees
Revolution Medicines vs
Blaze Bioscience
Blaze Bioscience United States

Dedicated to improving the lives of cancer patients

Series Unknown
25 employees
Biotechnology, Health Care
Compare Revolution Medicines vs Blaze Bioscience
Also compare with: Revolution Medicines vs Silenseed Silenseed

FAQ About Revolution Medicines

Translating Frontier Oncology Targets to Outsmart Cancer
Revolution Medicines was founded in 2014.
Revolution Medicines is headquartered in Redwood City, United States.
Revolution Medicines operates in the following industries: Biotechnology, Health Care, Life Sciences.
Revolution Medicines has approximately 1339 employees.
Revolution Medicines has completed 13 funding rounds, raising a total of $2.77B. The latest funding stage is IPO.
Top alternatives and competitors to Revolution Medicines include Alliance for Cancer Gene Therapy, Provectus Biopharmaceuticals, Blaze Bioscience, Eureka Genomics, Silenseed. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Revolution Medicines and Alliance for Cancer Gene Therapy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Revolution Medicines and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy